Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) — Financial Flexibility Index
Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥43.41 Million (operating CF CN¥8.57 Million minus capex CN¥34.84 Million) represents 0% of total liabilities (CN¥513.25 Million). Check 603168 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Shapuaisi Pharmaceutical Co Ltd Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Zhejiang Shapuaisi Pharmaceutical Co Ltd across 17 annual periods. See Zhejiang Shapuaisi Pharmaceutical Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
Year-by-year free cash flow to debt coverage for Zhejiang Shapuaisi Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market value of Zhejiang Shapuaisi Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.30x | CN¥153.78 Million | CN¥25.67 Million | CN¥516.59 Million | ▼ -49.8% |
| 2023 | 0.59x | CN¥261.29 Million | CN¥41.49 Million | CN¥440.92 Million | ▼ -46.0% |
| 2022 | 1.10x | CN¥264.41 Million | CN¥115.72 Million | CN¥240.99 Million | ▲ +0.5% |
| 2021 | 1.09x | CN¥254.23 Million | CN¥100.78 Million | CN¥232.89 Million | ▲ +553.5% |
| 2020 | 0.17x | CN¥61.27 Million | CN¥44.09 Million | CN¥366.78 Million | ▼ -79.0% |
| 2019 | 0.80x | CN¥79.80 Million | CN¥59.47 Million | CN¥100.28 Million | ▼ -16.1% |
| 2018 | 0.95x | CN¥158.75 Million | CN¥100.37 Million | CN¥167.41 Million | ▲ +26.1% |
| 2017 | 0.75x | CN¥159.57 Million | CN¥45.57 Million | CN¥212.13 Million | ▼ -44.2% |
| 2016 | 1.35x | CN¥334.27 Million | CN¥294.33 Million | CN¥247.88 Million | ▲ +143.6% |
| 2015 | 0.55x | CN¥212.21 Million | CN¥114.27 Million | CN¥383.37 Million | ▼ -75.8% |
| 2014 | 2.29x | CN¥250.52 Million | CN¥147.99 Million | CN¥109.44 Million | ▲ +194.9% |
| 2013 | 0.78x | CN¥189.59 Million | CN¥117.86 Million | CN¥244.26 Million | ▲ +35.1% |
| 2012 | 0.57x | CN¥139.18 Million | CN¥67.27 Million | CN¥242.33 Million | ▲ +61.0% |
| 2011 | 0.36x | CN¥44.74 Million | CN¥15.14 Million | CN¥125.43 Million | ▼ -1.9% |
| 2010 | 0.36x | CN¥25.62 Million | CN¥17.57 Million | CN¥70.45 Million | ▼ -24.9% |
| 2009 | 0.48x | CN¥37.36 Million | CN¥28.87 Million | CN¥77.15 Million | ▲ +38.5% |
| 2008 | 0.35x | CN¥24.21 Million | CN¥11.20 Million | CN¥69.24 Million | — |